Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Eric Lavonas to Animals

This is a "connection" page, showing publications Eric Lavonas has written about Animals.

 
Connection Strength
  
 
 
0.588
  
  1. Dezfulian C, Lavonas EJ. Precision Cardiac Arrest Resuscitation Based on Etiology. Crit Care Clin. 2020 Oct; 36(4):737-752.
    View in: PubMed
    Score: 0.041
  2. Lavonas EJ, Burnham RI, Schwarz J, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Anderson VE, Ginde AA, Gerardo CJ. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment. J Med Toxicol. 2020 01; 16(1):17-23.
    View in: PubMed
    Score: 0.038
  3. Lavonas EJ, Anderson VE, Gerardo CJ. In reply to Dr. Shah and Dr. Beuhler. Clin Toxicol (Phila). 2020 03; 58(3):223-224.
    View in: PubMed
    Score: 0.038
  4. Gerardo CJ, Vissoci JRN, Evans CS, Simel DL, Lavonas EJ. Does This Patient Have a Severe Snake Envenomation?: The Rational Clinical Examination Systematic Review. JAMA Surg. 2019 04 01; 154(4):346-354.
    View in: PubMed
    Score: 0.037
  5. Lavonas EJ, Anderson VE, Gerardo CJ. Response to carpenter and colleagues. Clin Toxicol (Phila). 2019 07; 57(7):674-676.
    View in: PubMed
    Score: 0.037
  6. Mullins ME, Gerardo CJ, Bush SP, Rose SR, Greene S, Quackenbush EB, Lewis B, Anderson VE, Kleinschmidt KC, Schwarz RB, Charlton NP, Toschlog EA, Sharma K, Denning DA, Lavonas EJ. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial. South Med J. 2018 12; 111(12):716-720.
    View in: PubMed
    Score: 0.036
  7. Lavonas EJ, Gerardo CJ. Letter to the editor: "Safety of nonsteroidal anti-inflammatory drugs in copperhead snakebite patients" by Pham and Mullins, Clin Toxicol 2018 May 18. Clin Toxicol (Phila). 2019 02; 57(2):144-145.
    View in: PubMed
    Score: 0.036
  8. Anderson VE, Gerardo CJ, Rapp-Olsson M, Bush SP, Mullins ME, Greene S, Toschlog EA, Quackenbush E, Rose SR, Schwartz RB, Charlton NP, Lewis B, Kleinschmidt KC, Sharma K, Lavonas EJ. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients. Clin Toxicol (Phila). 2019 01; 57(1):25-30.
    View in: PubMed
    Score: 0.035
  9. Gerardo CJ, Quackenbush E, Lewis B, Rose SR, Greene S, Toschlog EA, Charlton NP, Mullins ME, Schwartz R, Denning D, Sharma K, Kleinschmidt K, Bush SP, Ryan S, Gasior M, Anderson VE, Lavonas EJ. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue?Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Ann Emerg Med. 2017 Aug; 70(2):233-244.e3.
    View in: PubMed
    Score: 0.033
  10. Lavonas EJ, Gerardo CJ. Prospective study of recovery from copperhead snake envenomation: an observational study. BMC Emerg Med. 2015 May 15; 15:9.
    View in: PubMed
    Score: 0.028
  11. Gerardo CJ, Evans CS, Kuchibhatla M, Mando-Vandrick J, Drake WG, Yen M, Kopec K, Lavonas EJ. Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population. Acad Emerg Med. 2015 Mar; 22(3):308-14.
    View in: PubMed
    Score: 0.028
  12. Toschlog EA, Bauer CR, Hall EL, Dart RC, Khatri V, Lavonas EJ. Surgical considerations in the management of pit viper snake envenomation. J Am Coll Surg. 2013 Oct; 217(4):726-35.
    View in: PubMed
    Score: 0.025
  13. Lavonas EJ. Antivenoms for snakebite: design, function, and controversies. Curr Pharm Biotechnol. 2012 Aug; 13(10):1980-6.
    View in: PubMed
    Score: 0.023
  14. Schaeffer TH, Khatri V, Reifler LM, Lavonas EJ. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Acad Emerg Med. 2012 Feb; 19(2):121-31.
    View in: PubMed
    Score: 0.022
  15. Lavonas EJ, Fries JF, Furst DE, Rothman KJ, Stergachis A, Vaida AJ, Zelterman D, Reynolds KM, Green JL, Dart RC. Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf. 2012 Jan; 11(1):33-44.
    View in: PubMed
    Score: 0.022
  16. Lavonas EJ, Ruha AM, Banner W, Bebarta V, Bernstein JN, Bush SP, Kerns WP, Richardson WH, Seifert SA, Tanen DA, Curry SC, Dart RC. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011 Feb 03; 11:2.
    View in: PubMed
    Score: 0.021
  17. Lavonas EJ, Kokko J, Schaeffer TH, Mlynarchek SL, Bogdan GM, Dart RC. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011 Feb; 57(2):128-137.e3.
    View in: PubMed
    Score: 0.021
  18. Lavonas EJ, Schaeffer TH, Kokko J, Mlynarchek SL, Bogdan GM. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review. BMC Emerg Med. 2009 Jun 22; 9:13.
    View in: PubMed
    Score: 0.019
  19. Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W, Steffens M, Kerns WP. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004 Feb; 43(2):200-6.
    View in: PubMed
    Score: 0.013
  20. Lavonas EJ, Tomaszewski CA, Ford MD, Rouse AM, Kerns WP. Severe puff adder (Bitis arietans) envenomation with coagulopathy. J Toxicol Clin Toxicol. 2002; 40(7):911-8.
    View in: PubMed
    Score: 0.011
  21. Freiermuth CE, Lavonas EJ, Anderson VE, Kleinschmidt KC, Sharma K, Rapp-Olsson M, Gerardo C. Antivenom Treatment Is Associated with Fewer Patients using Opioids after Copperhead Envenomation. West J Emerg Med. 2019 May; 20(3):497-505.
    View in: PubMed
    Score: 0.009
  22. Gerardo CJ, Lavonas EJ, McKinney RE. Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation. Clin Trials. 2014 Oct; 11(5):560-4.
    View in: PubMed
    Score: 0.007
  23. Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, Kielstein JT, Mactier R, Maclaren R, Mowry JB, Bunchman TE, Juurlink D, Megarbane B, Anseeuw K, Winchester JF, Dargan PI, Liu KD, Hoegberg LC, Li Y, Calello DP, Burdmann EA, Yates C, Lalibert? M, Decker BS, Mello-Da-Silva CA, Lavonas E, Ghannoum M. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology. Clin Toxicol (Phila). 2012 Jun; 50(5):403-13.
    View in: PubMed
    Score: 0.006
  24. Thorson A, Lavonas EJ, Rouse AM, Kerns WP. Copperhead envenomations in the Carolinas. J Toxicol Clin Toxicol. 2003; 41(1):29-35.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)